Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
Source link
Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug
Date:
More like thisRelated
U.S. Crude Oil Stockpiles Fall More Than Expected
Commercial crude oil stocks were down by 8.3 million...
Chicago to Chivas: Gutiérrez is the American leading Mexico at this World Cup
GUADALAJARA, Mexico -- In what was likely a first...
Albuquerque offers cooling centers and shelters as temperatures rise
The city of Albuquerque is helping residents stay...